drugset / Trial / NCT00326183

Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED)

NCT00326183

Phase 4 Completed 1800 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupOpen-labelPrevention

Summary

Two doses each of Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella \[Oka/Merck\] Virus Vaccine Live will be given concomitantly or non-concomitantly. Safety data will be collected following each vaccination.

Timeline

Start
2007-03-26
Primary completion
2008-01-15
Completion
2008-01-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator ProQuad Vaccine 0.5 ml
Comparator Vaqta Vaccine 0.5 ml